Atrial fibrillation post coronary artery bypass graft. Paroxysmal atrial fibrillation
Conditions
Interventions
Intervention 1: Intervention group: Administration of rosuvastatin (chemical formula (C22H27FN3O6S)2Ca) 20 mg / day (manufactured by Atiya Pharmaceutical New Technologies (FNDA)) one week before coron
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to No maximum
Inclusion criteria
Inclusion criteria: The preoperative EKG of the patient must have sinus rhythm For the study, the patient must have satisfaction The patient must be a candidate for elective surgery The CABG surgery of the patient should be on pump
Exclusion criteria
Exclusion criteria: Urgent CABG surgery Previous cardiac surgery Cardiac surgery except CABG Left ventricular ejection fraction less than or equal to 25% Diameter of left atrium more than 6 cm in echocardiography Need to inotropic agents after surgery Being dependent on pace maker after surgery The patient's rhythm shouldn't be sinus. Hyperthyroidism Aortic and mitral valves disorder more than moderate Renal failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Incidence rate of atrial fibrillation post coronary artery bypass graft. Timepoint: Holter monitoring for 72 hours and daily ECG for one week and if it continues after one week, daily ECG will be taken until discharge.(up to 1 month). Method of measurement: Holter momitor and ECG devices. | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of diabetes and myopathy as possible complications of rosuvastatin. Timepoint: Fasting blood glucose and creatine phosphokinase measurement and clinical examination at the end of the first week and then at the end of the first month and then six months later. Method of measurement: Clinical examination and testing of fasting blood glucose and creatine phosphokinase. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactZahra Samadifar
Tabriz University of Medical Sciences
Outcome results
None listed